Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells
Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells
About this item
Full title
Author / Creator
Publisher
Dordrecht: Springer Netherlands
Journal title
Language
English
Formats
Publication information
Publisher
Dordrecht: Springer Netherlands
Subjects
More information
Scope and Contents
Contents
SRC, a non-receptor tyrosine kinase, is frequently over-expressed and highly activated in blood as well as solid tumors in various organs, including prostate, and has been associated with aggressive disease and a poor patient prognosis. Prostate cancer patients with a high risk of developing metastases have few treatment options, none of which can...
Alternative Titles
Full title
Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_916147078
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_916147078
Other Identifiers
ISSN
0262-0898
E-ISSN
1573-7276
DOI
10.1007/s10585-011-9436-2
